Ivor Elrifi


+1 212 479 6840

Dr. Ivor Elrifi is the chair of Cooley's global patent counseling and prosecution practice group. He advises pharmaceutical, biotechnology, life sciences and medical device companies, research institutions, universities, hospitals and governments throughout the world, particularly in the US and Europe. His practice includes patent prosecution, litigation, arbitration, licensing and transactional work with a focus on novel therapeutic treatments, biotechnology, genetics, diagnostics, biomarkers, drug formulations and medical devices.

Download full bio 


  • Ovid - $75 Million IPO 

  • Reata Pharmaceuticals – $505 Million Follow-On Offering 

  • Vir Biotechnology - $143 Million IPO 

  • Therachon Sells to Pfizer for up to $810 Million 

  • ERYTECH – $144 Million IPO 

  • View all

Patent Strategy & Management Attorney of the Year – LMG Life Sciences, 2019

  • Osgoode Hall Law School
    JD, 1989

  • Queen's University
    PhD, Biology, 1986

  • Queen's University
    BS, Biology

Admissions & Credentials



New York

Ontario, Canada

United States Patent & Trademark Office

Rankings & Accolades

    LMG Life Sciences: Patent Strategy & Management Attorney of the Year
    (2019, 2018, 2016)

    LMG Life Sciences: Life Sciences Star

    Euromoney: Global Leader in Patent Law

    Managing Intellectual Property: IP Star

    IAM Patent 1000: Leading Patent Lawyer

    Chambers and Legal 500: Leading Patent and Life Sciences Lawyer

    Super Lawyers: Top IP Lawyer


+1 212 479 6840 office
+1 212 479 6275 fax

55 Hudson Yards
New York, NY 10001-2157

Other Offices